Evidence map›Paper›PMID 42191932›Full record

ReviewNature reviews. Neurology2026

Motor neuron disease in Africa: a critical appraisal of the literature.

Jeannine M Heckmann, Niki Floudiotis, Akintomiwa Makanjuola, Adesola Ogunniyi, Andre Mochan, Rhanda R Mongwe, Dilraj S Sokhi, Melissa Nel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeannine M HeckmannNeurology Research Group, Department of Medicine and Neuroscience Institute, University of Cape Town, Cape Town, South Africa. jeanine.heckmann@uct.ac.za.ORCID http://orcid.org/0000-0002-8999-718X
Niki FloudiotisNeurology Research Group, Department of Medicine and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Akintomiwa MakanjuolaDepartment of Neurology, University College Hospital, Ibadan, Nigeria.ORCID http://orcid.org/0000-0003-1729-5987
Adesola OgunniyiDepartment of Neurology, University College Hospital, Ibadan, Nigeria.
Andre MochanDivision of Neurology, Department of Neurosciences, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Rhanda R MongweNeurology Research Group, Department of Medicine and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Dilraj S SokhiDepartment of Medicine, Medical College of East Africa (Nairobi Campus), Aga Khan University, Nairobi, Kenya.
Melissa NelClinical Omics and Informatics Unit, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-9698-992X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motor neuron disease (MND) refers to a group of neurodegenerative diseases that cause motor neuron degeneration and death. The most common subtype, amyotrophic lateral sclerosis (ALS), is characterized by both upper and lower motor neuron impairment, which can manifest clinically in the bulbar region or asymmetrically in a limb. Typically, the disease progresses over several months, and death from respiratory failure occurs within 2-5 years of onset. As we highlight in this Review, data on MND in Africa are sparse, although common observations in this region - and in other populations with relatively low life expectancy - include apparent earlier disease onset and lower disease incidence compared with the rest of the world. In view of the HIV epidemic in Africa, we critically examine the evidence for an association between ALS and HIV infection. We briefly discuss conditions that might be regarded as ALS mimics and summarize the limited data on MND genetics in this region. Other issues pertinent to people living with MND in Africa include the absence of cognitive and behavioural data and the limited access to multidisciplinary clinics, therapies and palliative care. We share our perspective on how the ALS Africa Network is coordinating a shift in the African MND landscape to improve patient care.

Indexed as

Motor Neuron DiseaseAfricaAmyotrophic Lateral SclerosisHIV InfectionsHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.